REVIEW
Add like
Add dislike
Add to saved papers

Selection and management of candidates for heart transplantation.

The increasing discrepancy between the donor hearts available and the number of patients with advanced heart failure underscores the need to optimize medical therapy and restrict the option of cardiac transplantation to patients with heart failure refractory to maximal conventional therapy. New medical and surgical therapies should be studied specifically in this population. The need for heart transplantation in ambulatory patients with severe heart failure is better assessed by the serial evaluation of objective measures of clinical stability and peak exercise oxygen consumption, than by assessment of standard risk factors at the time of patient referral. Among comorbidities which may preclude transplantation, psychosocial risk factors have recently undergone stricter scrutiny. The successful outcome of candidates for heart transplantation requires serial assessment and continuity of care by a dedicated team of health professionals specialized in heart failure and transplantation.

Full text links

Management of Latent Tuberculosis Infection.JAMA 2023 January 20
How I Treat Multiple myeloma in the geriatric patient.Blood 2023 January 25

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app